Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Abstract Text:

M Fukuda,K Horibe,K Furukawa,

We have evaluated the anti-tumor effect of anti-GD2 mouse monoclonal antibody (mAb) 220-51 against human neuroblastoma cell line TGW in vitro and in vivo. The mAb 220-51 was able to mediate complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) using human effector cells. In the presence of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte ADCC was significantly augmented in vitro. When mAb 220-51 was administered to tumor-bearing nude mice, tumor growth was significantly inhibited as compared with untreated controls. Administration of recombinant murine GM-CSF in combination with mAb 220-51 significantly enhanced the anti-tumor effect of mAb in vivo. Recombinant human granulocyte colony-stimulating factor (G-CSF) combined with mAb 220-51 was also able to enhance it, although granulocyte ADCC was not affected by the presence of recombinant human G-CSF in vitro. Moreover, GM-CSF and G-CSF work additively to enhance the anti-tumor effect of mAb 220-51 in vivo. The GM-CSF and G-CSF may have a clinical potency in immunotherapy with anti-GD2 mAb for the treatment of neuroblastoma.

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Publishing Authors By Initials

M Fukuda,K Horibe,K Furukawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of molecular medicine

VOLUME: 2

Page Numbers: 471-5

Journal Abbreviation: Int. J. Mol. Med.

ISSN: 1107-3756

DAY: 14

MONTH: Oct

YEAR: 1998

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9810955

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.

AFFILIATION: Department of Pediatrics, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

Country: Greece

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Mol Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor Related Publications

• Biogeochemical consequences of macrofauna burrow ventilationdagger.
• Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: A double-blind, placebo-controlled clinical trial.
• Comparison of sleep parameters at titration and subsequent compliance between CPAP-pretreated and non-CPAP-pretreated patients with obstructive sleep apnea.
• E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1.
• Emotional distress and its correlates among parents of children with pervasive developmental disorders.
• Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
• Evaluation of diagnostic criteria for panic attack using item response theory: Findings from the National Comorbidity Survey in USA.
• Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
• Feasibility of a membrane-aerated biofilm reactor to achieve single-stage autotrophic nitrogen removal based on Anammox.
• Functional roles of Otx2 transcription factor in postnatal mouse retinal development.
• Further observation of content uniformity of d-alpha-tocopheryl acetate as an oily drug in granules obtained by wet granulation with a high-shear mixer.
• Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: a hypothesis-generation study.
• In vitro Evaluation of Dose-Response Curve for Paclitaxel in Breast Cancer.
• Independent associations of alexithymia and social support with depression in hemodialysis patients.
• Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
• Mechanisms of neuronal death in synucleinopathy.
• Middle Turbinate Fenestration Method: A New Technique for the Treatment of Olfactory Disturbance due to Chronic Sinusitis.
• Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
• Nevoid basal cell carcinoma syndrome successfully treated with trichloroacetic acid and phenol peeling.
• Nuclear factor-kappaB activation in peripheral blood mononuclear cells in children with sepsis.
• Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
• Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study.
• Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
• Retinal blood oxygen saturation mapping by multispectral imaging and morphological angiography.
• Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro.
• Synthetic cinnamylphenol derivatives as cancer chemopreventive agents.
• The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
• The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training.
• Two dimensions of anosognosia in patients with Alzheimer's disease: Reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
• Undershirts coated with borage oil alleviate the symptoms of atopic dermatitis in children.